Clinical Trials Browser

INDUSTRY × Prostate Cancer Recurrent × tempol × Clear all

NCT04876755 2021-05-06

MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer

Phase 2 Unknown

Prostate Cancer Recurrent